A comprehensive view of liver/kidney/bladder health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

DaVita lists highlights from 2022, including referring over 92,000 patients for kidney transplants, with 7,800 patients receiving transplant, its highest number of annual transplants ever; record-setting 31,300 people participated in Kidney Smart class
Published: January 31, 2023 by DaVita Inc.
Eli Lilly, Boehringer Ingelheim announce FDA accepts sNDA for Jardiance empagliflozin, which is being investigated as a treatment to reduce risk of kidney disease progression, cardiovascular death in adults with chronic kidney disease
Published: January 20, 2023 by Eli Lilly & Co.
Bayer revises peak sales forecast for growth drivers in its pharma portfolio; peak sales projected to be over €12.0B, including projected sales of €3.0B for Nubeqa darolutamide prostate cancer drug, €3.0B in sales of Kerendia finerenone kidney drug
Published: January 11, 2023 by SeeNews Pharmaceuticals
Baxter to spin off its renal care, acute therapies business units into an independent company and simplify its commercial and manufacturing footprint to enhance performance; Baxter to also review strategic alternatives for its biopharma solutions business
Published: January 06, 2023 by Baxter Healthcare Corp
Seagen, Astellas and Merck announce FDA has accepted biologics license applications for PADCEV and KEYTRUDA for first-line treatment of certain urothelial cancers
Published: December 21, 2022 by ENP Newswire

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count